Lilly Covid antibodies cut hospitalizations and deaths

Anthony Barrington (“Barry”) Kay: part of the team that unequivocally established the Th2 T lymphocyte hypothesis for bronchial asthma
26 January 2021
Moderna Covid-19 jabs can be up to six weeks apart: WHO
26 January 2021

Lilly Covid antibodies cut hospitalizations and deaths

US pharmaceutical company Eli Lilly’s combination of two synthetic antibodies against COVID-19 reduced hospitalizations and deaths by 70 percent in high-risk patients with recent positive tests, the company said Tuesday.

Comments are closed.